Janux Therapeutics Stock Price Prediction
| JANX Stock | USD 48.82 1.49 2.96% |
Oversold Vs Overbought
53
Oversold | Overbought |
EPS Estimate Next Quarter (0.38) | EPS Estimate Current Year (1.25) | EPS Estimate Next Year (1.78) | Wall Street Target Price 67.25 | EPS Estimate Current Quarter (0.33) |
Using Janux Therapeutics hype-based prediction, you can estimate the value of Janux Therapeutics from the perspective of Janux Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Janux Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Janux because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Janux Therapeutics after-hype prediction price | USD 48.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Janux |
Janux Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Janux Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Janux Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Janux Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Janux Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Janux Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Janux Therapeutics' historical news coverage. Janux Therapeutics' after-hype downside and upside margins for the prediction period are 45.17 and 51.75, respectively. We have considered Janux Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Janux Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Janux Therapeutics is based on 3 months time horizon.
Janux Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Janux Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Janux Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Janux Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 3.29 | 0.36 | 0.00 | 9 Events / Month | 4 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
48.82 | 48.46 | 0.74 |
|
Janux Therapeutics Hype Timeline
Janux Therapeutics is currently traded for 48.82. The entity has historical hype elasticity of -0.36, and average elasticity to hype of competition of 0.0. Janux is estimated to decline in value after the next headline, with the price expected to drop to 48.46. The average volatility of media hype impact on the company price is about 193.53%. The price decrease on the next news is expected to be -0.74%, whereas the daily expected return is currently at 0.21%. The volatility of related hype on Janux Therapeutics is about 19740.0%, with the expected price after the next announcement by competition of 48.82. About 95.0% of the company shares are owned by institutional investors. The book value of Janux Therapeutics was currently reported as 12.54. The company recorded a loss per share of 1.17. Janux Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 9 days. Check out Janux Therapeutics Basic Forecasting Models to cross-verify your projections.Janux Therapeutics Related Hype Analysis
Having access to credible news sources related to Janux Therapeutics' direct competition is more important than ever and may enhance your ability to predict Janux Therapeutics' future price movements. Getting to know how Janux Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Janux Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| HCWB | HCW Biologics | 0.01 | 4 per month | 8.16 | 0.08 | 22.00 | (16.67) | 352.85 | |
| SCPH | Scpharmaceuticals | (0.1) | 7 per month | 0.00 | (0.21) | 4.05 | (7.09) | 20.70 | |
| MIST | Milestone Pharmaceuticals | 0.05 | 7 per month | 1.61 | 0.09 | 7.19 | (2.11) | 18.66 | |
| MCRB | Seres Therapeutics | (0.06) | 9 per month | 5.66 | 0.02 | 10.84 | (9.78) | 28.84 | |
| LUMO | Lumos Pharma | (0.05) | 6 per month | 2.72 | 0.05 | 5.95 | (5.19) | 16.25 |
Janux Therapeutics Additional Predictive Modules
Most predictive techniques to examine Janux price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Janux using various technical indicators. When you analyze Janux charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Janux Therapeutics Predictive Indicators
The successful prediction of Janux Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Janux Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Janux Therapeutics based on analysis of Janux Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Janux Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Janux Therapeutics's related companies. | 2022 | 2023 | 2024 (projected) | Interest Debt Per Share | 0.71 | 0.56 | 0.59 | Revenue Per Share | 0.21 | 0.18 | 0.13 |
Story Coverage note for Janux Therapeutics
The number of cover stories for Janux Therapeutics depends on current market conditions and Janux Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Janux Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Janux Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Janux Therapeutics Short Properties
Janux Therapeutics' future price predictability will typically decrease when Janux Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Janux Therapeutics often depends not only on the future outlook of the potential Janux Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Janux Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44 M | |
| Cash And Short Term Investments | 344 M |
Additional Tools for Janux Stock Analysis
When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.